Table 18. Summary of HIEPC-related procedures in different PC institutions or countries (published researches).

Country /No. Institutions	Major Institutions	No. patients	Mode	HIPEC-MMC alone	HIPEC-MMC+DDP	HIPEC-L-OHP alone	HIPEC-other	Temperature (°C)	Duration (min)
China, 1	Zhongnan Hospital of Wuhan University [39]
Subtotal		62	O		MMC (30 mg) + DDP (120 mg)			43.0±0.5	90
Norway, 1	Norwegian Radium Hospital [103]
Subtotal		109	O/C	35 mg/m2				41.4 (39.5-42.1)	90
Denmark, 1	Aarhus University Hospital [60, 75]
Subtotal		53	O	35 mg/m2				41-42.5	90
Germany, 1	University of Wuerzburg Medical Centre [15, 29, 72]
Subtotal		>11	O	10-20 mg/m2		Y		42 /40-43	90 /30
Israel. 1	Tel Aviv Medical Center [13]
Subtotal		25	O/C	Y	Y	Y	MMC+CPT-11, 5-FU	40-43	30-90
Japan, 1	Shizuoka Cancer Centre [13]
Subtotal		25	O/C	Y	Y	Y	MMC+CPT-11, 5-FU	40-43	30-90
Mexico, 1	Instituto Jalisciense de Cancerologia [29, 72]
Subtotal		?	O/C	Y		Y		40-43	30-120
Serbia and Montenegro, 1	First Surgical University Hospital, Clinical Center of Serbia [61]
Subtotal		18	C	10 or 12.5 mg/m2				42	120

Note: C: closed abdomen technique for HIPEC; O: open abdomen technique for HIPEC; Y: yes; MMC: mitomycin C; DDP: cisplatin; 5-FU: fluorouracil; L-OHP: oxaliplatin; CPT-11: irinotecan